Tuesday - August 4, 2026
GSK's Shingrix New Prefilled Syringe Presentation Receives Positive CHMP Opinion
October 21, 2025
LONDON, England, Oct. 21 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK's Shingrix new prefilled syringe presentation receives positive CHMP opinion

* Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals

* Marketing authorisation in EU expected in December 2025

* Shingles affects approximately 1.7 million people in Eur . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products